Copyright: ©Author(s) 2026.
World J Stem Cells. Oct 26, 2026; 18(10): 124640
Published online Oct 26, 2026. doi: 10.4252/wjsc.124640
Published online Oct 26, 2026. doi: 10.4252/wjsc.124640
Figure 4 Human bone-marrow-derived mesenchymal stem cells alleviated hippocampal neuroinflammation in stressed mice.
A: Western blot plot of protein in the different groups; B-G: Relative expression levels of CD68 (B), ionized calcium-binding adapter molecule 1 (C), arginase 1 (D), tumor necrosis factor-α (E), transforming growth factor-β (F), interleukin-10 (G), and normalized to GAPDH. aP < 0.05, bP < 0.01, cP < 0.001. Data were analyzed using one-way analysis of variance followed by Tukey’s multiple-comparisons test (mean ± SEM, n = 4 per group). TGF: Transforming growth factor; Arg1: Arginase 1; TNF: Tumor necrosis factor; IL: Interleukin; Iba1: Ionized calcium-binding adapter molecule 1.
- Citation: Liu Y, Wu JF, Xu MY, Kang J, Ye AH, Liu B, Liu KZ. Human bone marrow-derived mesenchymal stem cells alleviate fluoxetine-resistant depression-like behaviors in mice by multi-target effects in the hippocampus. World J Stem Cells 2026; 18(10): 124640
- URL: https://www.wjgnet.com/1948-0210/full/v18/i10/124640.htm
- DOI: https://dx.doi.org/10.4252/wjsc.124640